Document is current
Any future updates will be listed below
-
Authors
Walker, Daisy
Moucheraud, Corrina
Butler, Derrick
de Vente, Jerome
Tangonan, Kevin
Shoptaw, Steven
Currier, Judith S.
Gladstein, Jay
Hoffman, Risa
-
Funding
Funding for this research was provided by:
California HIV/AIDS Research Program
- License Information
-
More Information
Article History
Received: 26 September 2022
Accepted: 25 January 2023
First Online: 15 February 2023
Declarations
:
: The study was approved by the Institutional Review Board at the University of California, Los Angeles (IRB #20–001508). Informed consent was obtained from all individual participants included in the study, and all methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: JSC served as a Scientific Advisor for Merck and Company in 2021. JG is on the Speaker Bureau for Gilead Sciences and ViiV Healthcare; he has also conducted clinical trials sponsored by both organizations. RH serves on the Editorial Board of Elsevier’s Clinical Key, an online resource for clinicians. The remaining authors declare that they have no competing interests.
